Breaking News
Clinical Trial Cleared for GPH101: The First Potentially Curative Sickle Cell Disease Therapy
Blood Supply Challenges & Transfusion Care of Patients With Haemoglobinopathies During COVID-19 Pandemic
EdiGene Announces Approval in China of its IND Application for CRISPR/Cas 9 Gene Editing Therapy ET-01 in β-thalassaemia
The New Issue of the TIF Newsletter Is Just Released
TIF Newsletter – December 2020
Just Updated: TIF’s Vaccinations & Therapeutic Drugs for COVID-19 Guide
Iranian Blood Transfusion Organization Newsletter – December 2020
Blood Under The Microscope Of The European Commission: An Article by TIF’s Executive Director
THALIA App: The Skilled Digital Assistant of People with Thalassaemia and Sickle Cell Disease
COVID-19 Vaccines and Haemoglobin Disorders: The Latest Position Statement of the Thalassaemia International Federation
English
Ελληνικά
Français
Deutsch
Italiano
العربية
Menu
Home
Who we are
TIF History
Vision & Mission
Pillars of Work
Board of Directors
Staff Members
TIF Members
Collaborations
Transparency
Awards & Honours
What we do
Education
Country work
Projects
Haemoglobin Disorders
Thalassaemia
Sickle Cell Disease
Clinical Trial Updates
Positions & Policies
Policy Framework
Position Papers
Official Statements
Publications
TIF Publications
Scientific Literature
Additional Resources
Media Centre
News
Newsletters
Events
Videos
Contact us
Search for
RSS
Instagram
YouTube
Twitter
Facebook
Home
/
Alpha thalassaemia
Alpha thalassaemia
Virtual Conference on Alpha Thalassaemia Major By UCSF on 8-9 January 2021
News
November 24, 2020
Virtual Conference on Alpha Thalassaemia Major By UCSF on 8-9 January 2021
The Center for Maternal-Fetal Precision Medicine (UCSF) will host a 2-day online international conference on Alpha Thalassaemia Major, which was once considered universally fatal in utero, on 8-9 January 2021. …
Back to top button
Close
Search for
Close
Log In
Forget?
Remember me
Log In
Cookies
This site uses cookies.
Find out more
Okay, thanks